Oruka Therapeutics Inc. Common Stock vs Southern Copper Corp — how do they compare? Oruka Therapeutics Inc. Common Stock trades at $75.2 (market cap $5.18B), while Southern Copper Corp trades at $199.15 (market cap $175.13B). The key difference: Southern Copper Corp is far larger — about 33.8× Oruka Therapeutics Inc. Common Stock's market cap, and Southern Copper Corp pays a 2.12% dividend while Oruka Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Oruka Therapeutics Inc. Common Stock for 0 Days and Southern Copper Corp for 62 Days on average.
| ORKA | SCCO | |
|---|---|---|
Market Cap | $5.18B | $175.13B |
Volume | 490,798 | 611,484 |
Sector | Health | Basic Materials |
52-Week High | $113.08 | $219.70 |
52-Week Low | $26.19 | $120.02 |
Typical Hold Time | 0 Days | 62 Days |
Enterprise Value | $4.31B | $176.43B |
Dividend Yield | — | 2.12% |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Southern Copper (SCCO) trades at $200.68, down 3.84% on the day, but maintains strong fundamentals with impressive earnings beats and robust profitability metrics. The company shows consistent revenue growth from $10.0B in 2022 to $13.4B in 2025, with net income margins expanding to 35.87%. Technical indicators show a bullish trend with support at $204 and resistance at $210, while analyst sentiment remains divided with a consensus price target of $165.60.
SCCO presents a mixed investment case with exceptional profitability and growth prospects from its Mexican projects, but faces valuation concerns with a P/E of 31.12 and divided analyst ratings. Key risks include copper price volatility and execution challenges, while institutional interest remains active with recent purchases by Virginia Retirement Systems.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Oruka Therapeutics, Inc. is a clinical-stage biotechnology company developing extended half-life monoclonal antibodies for plaque psoriasis, psoriatic arthritis, and related dermatologic conditions, with lead candidates ORKA-001 and ORKA-002 in clinical trials.
Read more on ORKA →Southern Copper Corp is an integrated producer of copper and other minerals and operates the mining, smelting, and refining facilities in Peru and Mexico. Its production includes copper, molybdenum, zinc, and silver. The company operates through the following segments: Peruvian operations, Mexican open-pit operations, and Mexican underground mining operations. Southern Copper generates the majority of its revenue from the sale of copper and the rest from the sale of non-copper products, such as molybdenum, silver, zinc, lead, and gold. Its geographical segments are The Americas, Europe, and Asia.
Read more on SCCO →